Cargando…

Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775857/ https://www.ncbi.nlm.nih.gov/pubmed/31632008 http://dx.doi.org/10.2147/IJN.S231687

Ejemplares similares

Targeted Delivery of Doxorubicin Utilizing Chitosan Nanoparticles Surface Functionalized with Anti Her2 Trastuzumab [Corrigendum]
Publicado: (2022)

Targeted delivery of doxorubicin to HER2 positive tumor models
por: Gomari, Hosna, et al.
Publicado: (2019)

Down-Regulation of USP8 Suppresses HER-3 Positive Gastric Cancer Cells Proliferation [Corrigendum]
Publicado: (2021)

Corrigendum to “Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib”
por: Gorini, Stefania, et al.
Publicado: (2019)

Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum]
Publicado: (2019)

Corrigendum to “Hydrogen-Rich Saline Attenuates Cardiac and Hepatic Injury in Doxorubicin Rat Model by Inhibiting Inflammation and Apoptosis”
por: Gao, Yunan, et al.
Publicado: (2017)

CORRIGENDUM to “Dual-targeting strategy using trastuzumab and lapatinib in a patient with HER2 gene amplification in recurrent metachronous metastatic gallbladder carcinoma”
Publicado: (2020)

Corrigendum to “Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling”
por: Cheng, Xiaoli, et al.
Publicado: (2022)

CD-340 Functionalized Doxorubicin-Loaded Nanoparticle Induces Apoptosis And Reduces Tumor Volume Along With Drug-Related Cardiotoxicity In Mice [Corrigendum]
Publicado: (2019)

CD-340 Functionalized Doxorubicin-Loaded Nanoparticle Induces Apoptosis and Reduces Tumor Volume Along with Drug-Related Cardiotoxicity in Mice [Corrigendum]
Publicado: (2021)

Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [(14)C]-doxorubicin [Corrigendum]
Publicado: (2016)

Corrigendum to “Drug Delivery Nanoparticles in Skin Cancers”
por: Dianzani, Chiara, et al.
Publicado: (2021)

Construction and in vivo/in vitro Evaluation of a Nanoporous Ion-Responsive Targeted Drug Delivery System for Recombinant Human Interferon α-2b Delivery [Corrigendum]
Publicado: (2021)

Folic Acid-Targeted Disulfide-Based Cross-Linking Micelle for Enhanced Drug Encapsulation Stability and Site-Specific Drug Delivery Against Tumors [Corrigendum]
Publicado: (2021)

Corrigendum to: A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma
por: Butt, Omar H, et al.
Publicado: (2022)

Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin [Corrigendum]
Publicado: (2021)

Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature [Corrigendum]
Publicado: (2022)

Validation of second trimester miscarriages and spontaneous deliveries [Corrigendum]
Publicado: (2017)

Corrigendum to “NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation”
por: Butt, Zeeshan, et al.
Publicado: (2018)

In vivo targeted gene delivery to peripheral neurons mediated by neurotropic poly(ethylene imine)-based nanoparticles [Corrigendum]
Publicado: (2017)

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era [Corrigendum]
Publicado: (2015)

Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum]
Publicado: (2021)

Corrigendum to “Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice”
por: Zhang, Jianwei, et al.
Publicado: (2022)

Carbon Nanotubes: Smart Drug/Gene Delivery Carriers [Corrigendum]
Publicado: (2021)

Corrigendum to “New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy”
por: Guo, Qiujun, et al.
Publicado: (2018)

Targeted delivery of reduced graphene oxide nanosheets using multifunctional ultrasound nanobubbles for visual and enhanced photothermal therapy [Corrigendum]
Publicado: (2019)

The synthesis and application of nano doxorubicin-indocyanine green matrix metalloproteinase-responsive hydrogel in chemophototherapy for head and neck squamous cell carcinoma [Corrigendum]
Publicado: (2019)

Doxorubicin-Loaded Poly (Lactic-Co-Glycolic Acid) Nanoparticles Coated with Chitosan/Alginate by Layer by Layer Technology for Antitumor Applications [Corrigendum]
Publicado: (2021)

Corrigendum to “Efficient gene delivery to photoreceptors using AAV2/rh10 and rescue of the Rho–/– mouse”
por: Palfi, Arpad, et al.
Publicado: (2016)

Corrigendum: Neglected tumor in a female with albinism
por: Filho, Fred Bernardes
Publicado: (2018)

Synthesis of biocompatible iron oxide nanoparticles as a drug delivery vehicle [Corrigendum]
Publicado: (2018)

Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum]
Publicado: (2021)

Intrathecal Drug Delivery Systems Survey: Trends in Utilization in Pain Practice [Corrigendum]
Publicado: (2023)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment [Corrigendum]
Publicado: (2021)

Inhibition of Proliferation and Migration of Tumor Cells Through Phenylboronic Acid-Functionalized Polyamidoamine-Mediated Delivery of a Therapeutic DNAzyme Dz13 [Corrigendum]
Publicado: (2021)

Cell penetrating peptide-modified nanoparticles for tumor targeted imaging and synergistic effect of sonodynamic/HIFU therapy [Corrigendum]
Publicado: (2019)

[Corrigendum] MicroRNA‑92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7
por: Yang, Wei, et al.
Publicado: (2023)

40 years of Alma Ata Malaysia: Targeting equitable access through organisational and physical adaptations in the delivery of public sector primary care – CORRIGENDUM
por: Fadzil, Fariza, et al.
Publicado: (2020)

Corrigendum to “Evaluation and Management of Skeletal Health in Celiac Disease: Position Statement”
por: Fouda, Mona A., et al.
Publicado: (2017)

Corrigendum to “Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch” [Redox Biol. 52 (2022) 1–16/102311]
por: Ding, Mingge, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q6nln11dcgae0murodhh4qiche